We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
Reserve Bar Stock Exchange weaves mobile technology across a multi-floor venue to create a unique experience within The City at 46 Gresham St.
days to go: Expired investment: Withheld
Silo offers a unique dining experience by promoting a pre-industrial food system that generates zero material waste and celebrating whole pure foods born from clean farming. Aspiring to revolutionise the food industry by being ethical and productive, Silo is evolving as one of the world's first zero-waste and environment-friendly restaurants. Silo is confident that it has a profitable untapped market that can be exploited with its unique concept. The funds raised will be used to make a zero-carbon delivery system, using non-native goods such as green coffee beans, red wine and cacao.
days to go: Expired investment: £48,000
Yumbles is a leading UK online marketplace for artisan food. It currently connects over 600 independent food makers directly with consumers. The company is targeting the UK’s estimated £10bn+ UK Speciality Food & Drink market, having seen £1m+ sales in the last 12 months resulting in £400k+ revenue.
days to go: Expired investment: £262,080
Fireaway pizza orginally started out as a modest pizzeria in south London in 2016, we've expanded to 159 franchises, achieving a remarkable 106% compound annual growth rate in store expansion. With franchise sales reaching £59 million annually, we became debt-free in 2022, boasting an EBITDA of £1.31 million and HQ revenue of £14.5 million in FY23. As a profitable venture, we invite you to join us and be part of our promising growth trajectory.
days to go: Expired investment: £532,336
Wriggle is a real-time marketplace which creates a list of amazing eat-out food & drinking establishments for its users. The users search and pay directly using its mobile application and head to their chosen establishments. It has a transactional platform in three cities and is currently generating over 20,000 transactions per month. In March 2019, Wriggle has witnessed a monthly revenue of 175K. Wriggle has also won the Sparkies Awards Best App (twice). With the proceeds, Wriggle is planning to launch in new cities in the UK, increase revenue in the existing cities, and grow its technological team.
days to go: Expired investment: £940,290
Guest are creating the world's best cocktail bar. They aim to do this by offering a new menu from some of the most creative food and cocktail innovators in the world. With the money invested Guest are going to place a deposit on a venue for the bar, refurbish and fit out the venue and then start an international marketing campaign.  
days to go: Expired investment: £107,180
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph